The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Nitric Oxide Signaling in Pain and Nociceptor Sensitization in the Rat
Open accessAbstract
We investigated the role of nitric oxide (NO) in inflammatory hyperalgesia. Coinjection of prostaglandin E2 (PGE2) with the nitric oxide synthase (NOS) inhibitor NG-methyl-L-arginine (L-NMA) inhibited PGE2-induced hyperalgesia. L-NMA was also able to reverse that hyperalgesia. This suggests that NO contributes to the maintenance of, as well as to the induction of, PGE2-induced hyperalgesia. Consistent with the hypothesis that the NO that contributes to PGE2-induced sensitization of primary afferents is generated in the dorsal root ganglion (DRG) neurons themselves, L-NMA also inhibited the PGE2-induced increase in tetrodotoxin-resistant sodium current in patch-clamp electrophysiological studies of small diameter DRG neurons in vitro. Although NO, the product of NOS, often activates guanylyl cyclase, we found that PGE2-induced hyperalgesia was not inhibited by coinjection of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), a guanylyl cyclase inhibitor. We then tested whether the effect of NO depended on interaction with the adenylyl cyclase-protein kinase A (PKA) pathway, which is known to mediate PGE2-induced hyperalgesia. L-NMA inhibited hyperalgesia produced by 8-bromo-cAMP (a stable membrane permeable analog of cAMP) or by forskolin (an adenylyl cyclase activator). However, L-NMA did not inhibit hyperalgesia produced by injection of the catalytic subunit of PKA. Therefore, the contribution of NO to PGE2-induced hyperalgesia may occur in the cAMP second messenger pathway at a point before the action of PKA. We next performed experiments to test whether administration of exogenous NO precursor or donor could mimic the hyperalgesic effect of endogenous NO. Intradermal injection of either the NOS substrate L-arginine or the NO donor 3-(4-morphinolinyl)-sydnonimine hydrochloride (SIN-1) produced hyperalgesia. However, this hyperalgesia differed from PGE2-induced hyperalgesia, because it was independent of the cAMP second messenger system and blocked by the guanylyl cyclase inhibitor ODQ. Therefore, although exogenous NO induces hyperalgesia, it acts by a mechanism different from that by which endogenous NO facilitates PGE2-induced hyperalgesia. Consistent with the hypothesis that these mechanisms are distinct, we found that inhibition of PGE2-induced hyperalgesia caused by L-NMA could be reversed by a low dose of the NO donor SIN-1. The following facts suggest that this dose of SIN-1 mimics a permissive effect of basal levels of NO with regard to PGE2-induced hyperalgesia: (1) this dose of SIN-1 does not produce hyperalgesia when administered alone, and (2) the effect was not blocked by ODQ. In conclusion, we have shown that low levels of NO facilitate cAMP-dependent PGE2-induced hyperalgesia, whereas higher levels of NO produce a cGMP-dependent hyperalgesia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors.
Gold, M. S., Reichling, D. B., Shuster, M. J., & Levine, J. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.3.1108 · Cited by 668
Self-citationEngland, S., Bevan, S., & Docherty, R. J. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021604 · Cited by 549
Moore, P. K., Wallace, P., Gaffen, Z., Hart, S. L., & Babbedge, R. C. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13795.x · Cited by 459
The hyperalgesic effects of prostacyclin and prostaglandin E2
FERREIRA, S., NAKAMURA, M., & DEABREUCASTRO, M. (1978) · Prostaglandins · doi:10.1016/0090-6980(78)90199-5 · Cited by 355
Nitric Oxide: A Neural Messenger
Jaffrey, S. R., & Snyder, S. H. (1995) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.11.110195.002221 · Cited by 349
Gopalakrishna, R., Chen, Z. H., & Gundimeda, U. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74235-5 · Cited by 299
taiwo, Y. O., & levine, J. D. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90255-m · Cited by 241
Self-citationExcitation and sensitization of fine articular afferents from cat's knee joint by prostaglandin E2.
Schaible, H. G., & Schmidt, R. F. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017240 · Cited by 233
Martin, H. A., Basbaum, A. I., Kwiat, G. C., Goetzl, E. J., & Levine, J. D. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90360-5 · Cited by 227
Self-citationZhang, X., Verge, V., Wiesenfeld‐Hallin, Z., Ju, G., Bredt, D., Snyder, S. H., & Hökfelt, T. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903350408 · Cited by 209
Cited by
Role of the Immune system in chronic pain
Marchand, F., Perretti, M., & McMahon, S. B. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1700 · Cited by 1,098
Aley, K. O., Messing, R. O., Mochly-Rosen, D., & Levine, J. D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04680.2000 · Cited by 332
Self-citationChemokines: Integrators of Pain and Inflammation
White, F. A., Bhangoo, S. K., & Miller, R. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1852 · Cited by 280
Intracellular Signaling in Primary Sensory Neurons and Persistent Pain
Cheng, J.-K., & Ji, R.-R. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9711-z · Cited by 266
Metadata
- Authors
- Aley, K. O., McCarter, G., & Levine, J. D.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 1998-09-01
- Volume
- 18
- Issue
- 17
- Pages
- 7008-7014
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1954733039
- Cited by
- 264
- References
- 40
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nitric Oxide Signaling in Pain and Nociceptor Sensitization in the Rat. https://app.cochat.ai/papers/10.1523/jneurosci.18-17-07008.1998
- The paper
- Aley, K. O., McCarter, G., & Levine, J. D. (1998). Nitric Oxide Signaling in Pain and Nociceptor Sensitization in the Rat. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.18-17-07008.1998
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.